Rolley, C.; Zidane, M.; Nedelcu, C.; Barth, M.; Saulnier, P.; Procaccio, V.; Bigot, P. Feasibility and Safety of a Ketogenic Diet During Systemic Therapy for Metastatic Renal Cell Carcinoma: Results from the Cetorein Pilot Study. Nutrients 2026, 18, 1712. https://doi.org/10.3390/nu18111712

AMA Style

Rolley C, Zidane M, Nedelcu C, Barth M, Saulnier P, Procaccio V, Bigot P. Feasibility and Safety of a Ketogenic Diet During Systemic Therapy for Metastatic Renal Cell Carcinoma: Results from the Cetorein Pilot Study. Nutrients. 2026; 18(11):1712. https://doi.org/10.3390/nu18111712

Chicago/Turabian Style

Rolley, Cyrielle, Merzouka Zidane, Cosmina Nedelcu, Magalie Barth, Patrick Saulnier, Vincent Procaccio, and Pierre Bigot. 2026. "Feasibility and Safety of a Ketogenic Diet During Systemic Therapy for Metastatic Renal Cell Carcinoma: Results from the Cetorein Pilot Study" Nutrients 18, no. 11: 1712. https://doi.org/10.3390/nu18111712

APA Style

Rolley, C., Zidane, M., Nedelcu, C., Barth, M., Saulnier, P., Procaccio, V., & Bigot, P. (2026). Feasibility and Safety of a Ketogenic Diet During Systemic Therapy for Metastatic Renal Cell Carcinoma: Results from the Cetorein Pilot Study. Nutrients, 18(11), 1712. https://doi.org/10.3390/nu18111712

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI